Why the study?
Does immunomodulatory therapy improve outcomes in patients with chronic heart failure?
Population
Patients with chronic heart failure
Comparison
Immunomodulatory therapy vs Placebo
Design
Review
Authors
Loading...
Anti-TNF therapy lacks support in heart failure; leaves open targeted cytokine modulation for future trials.
Does immunomodulatory therapy improve outcomes in patients with chronic heart failure?
Despite the pathogenic role of inflammation in chronic heart failure, current anti-TNF therapies have not shown clinical benefit, highlighting the need for more specific immunomodulating agents.
Aukrust et al. (2005) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: